Future studies should thus analyse the regulation of the PD-1/PD-L1 axis in larger patient cohorts, exploring treatment responses, investigating in-depth subgroup analyses and including longitudinal samples of stable versus relapsing and progressive MS patients. Here, PDCD1 is linked to myeloid sarcoma.